Tamoxifen and Risk of Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersKelly‐Anne Phillips, John L. Hopper, Matti A. Rookus et al.|Journal of Clinical Oncology|2013Cited by 171